Le Lézard
Classified in: Transportation, Science and technology, Covid-19 virus
Subject: Contract/Agreement

Avetta and Hound Labs Partner to Bring the World's First On-Site Test for Recent Marijuana Use to the Supply Chain Industry


Avetta®, the leading provider of supply chain risk management, and Hound Labs, Inc. have partnered to provide supply chain companies in the Avetta Marketplace with the HOUND® MARIJUANA BREATHALYZER. The breathalyzer is the world's first ultra-sensitive solution for detecting and measuring recent marijuana use in breath. The solution will reach general availability this spring, and quotes are now available for Avetta Marketplace members to secure a system at a discounted rate.

"Hound Labs' solution is a key method to help both employees and companies maintain safety in all areas of the supply chain," said Richard Parke, SVP Supplier Services at Avetta. "Companies now have an accurate way to determine whether or not employees recently used marijuana prior to coming to the job site. This process is especially critical in states where recreational marijuana use is legal."

Drug tests that analyze oral fluid, hair, blood and urine can tell only whether someone used marijuana at some point in the past?up to hours, days, weeks or months ago?long after impairment subsides. The HOUND MARIJUANA BREATHALYZER is a fairer test because it measures THC in breath for the few hours that correlate with peak impairment. Testing only recent marijuana use within the peak impairment window1 avoids basing employment decisions on irrelevant information about past use. Using the Hound Labs breathalyzer maintains workplaces as impairment-free environments, promoting safety and productivity of employees.

"The HOUND MARIJUANA BREATHALYZER provides Avetta member companies with a critical tool to help ensure their workplaces are safe without having to base employment decisions on positive tests for past marijuana use that may have legally occurred after work hours," said Mike Lynn, CEO and Co-Founder of Hound Labs.

Avetta's Marketplace also allows suppliers to purchase discounted safety products and other safety-related services. Marketplace enhances membership value by reducing costs, saving time, improving performance and growing the businesses of contractors and suppliers who participate. Avetta was the first in the industry to offer a "Marketplace" of these kinds of value-added services.

For more information about the HOUND MARIJUANA BREATHALYZER, visit the Avetta Marketplace.

About Avetta

Avetta leads the world in connecting leading global organizations across several industries, including oil/gas, telecom, construction materials, facilities management and many others, with qualified and vetted suppliers, contractors and vendors. The company brings unmatched access and visibility to its clients' supply chain risk management process through its innovative and configurable technology, coupled with highly experienced human knowledge and insight. We contribute to the advancement of our clients' sustainable growth by protecting supply chains from a wide range of potential risks through trusted contractor prequalification, safety training and monitoring, regulatory compliance, insurance/financial stability and other areas of risk. Avetta currently serves more than 450 enterprise companies and 100K suppliers across 100+ countries. Visit www.avetta.com for more information.

About Hound Labs, Inc.

Hound Labs is a point-of-care health technology company that combines science and technology in novel ways to improve health and wellness. The Company believes its ultra-sensitive and portable technologies will pave the way to practical and fair solutions for some of the leading public health and safety issues. Hound Labs' point-of-care solutions include the HOUND® MARIJUANA BREATHALYZER2, which allows employers and law enforcement to identify recent marijuana use rapidly and accurately by testing breath on-site, and the HOUND® COVID-19 BREATHALYZER, which captures breath samples on-location for laboratory identification of COVID-19. The Oakland-based company was founded in 2014 by a team, including CEO Dr. Mike Lynn, an ER physician, reserve deputy sheriff, and former venture capitalist. Benchmark, Icon Ventures, Intrinsic Capital Partners, Main Street Advisors, NFP Ventures, and individual investors have funded the Company.

The HOUND® MARIJUANA BREATHALYZER is intended to detect recent marijuana use. It does not measure whether, or how much, a person is impaired. It is intended solely for use in law enforcement, employment, and insurance settings. It should not be used for any medical or therapeutic purposes, or for any Federal drug testing programs, such as programs run by the Substance Abuse and Mental Health Services Administration (SAMHSA), the Department of Transportation (DOT), and the U.S. military.

1 https://www.nhtsa.gov/sites/nhtsa.dot.gov/files/809725-drugshumanperformfs.pdf

2 The HOUND MARIJUANA BREATHALYZER is intended to detect recent marijuana use. It does not measure whether, or how much, a person is impaired. It is intended solely for use in law enforcement, employment, and insurance settings. It should not be used for any medical or therapeutic purposes, or for any Federal drug testing programs, such as programs run by the Substance Abuse and Mental Health Services Administration (SAMHSA), the Department of Transportation (DOT), and the U.S. military.


These press releases may also interest you

at 18:00
Voxtur Analytics Corp. , a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market...

at 18:00
On April 19, 2024, the board of directors of Portland General Electric Company declared a quarterly common stock dividend of $0.50 per share, representing an increase of 5.3%, or $0.10 per share, on an annualized basis. The company's dividend is...

at 17:52
Adyton Resources Corporation  ("Adyton" or the "Company") announces it has closed its previously announced non-brokered private placement offering, pursuant to which it has issued 50,000,000 common shares of the Company ("Shares") at a price of...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
Lion Group Holding Ltd. ("Lion" or "the Company") , the operator of an all-in-one trading platform that offers a wide spectrum of products and services, today announced that on April 18, 2024, it received a delinquency notification letter from the...

at 16:30
Cosmos Health Inc. ("Cosmos Health" or the "Company'') , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...



News published on and distributed by: